Event
Nordic Life Science Days 2026 | Axxam
Aurelie Dos Santos
Associate
BD & Sales France Benelux Nordics
Building New Drug Discovery Collaboration at Nordic Life Science Days 2026
Scientific innovation is driven not only by breakthrough ideas but also by the collaborations that transform those ideas into reality. Nordic Life Science Days (NLSDays) 2026 is one of Europe’s leading life science partnering events, bringing together biotechnology companies, pharmaceutical organizations, investors, academic researchers, service providers and industry leaders to foster new collaborations and accelerate innovation across the healthcare ecosystem.
Taking place in Stockholm on 8–9 September 2026, the event provides an ideal environment to explore emerging technologies, discuss scientific challenges and identify strategic partnerships that can help advance drug discovery and development programs.
Axxam is pleased to participate in Nordic Life Science Days 2026, where we look forward to meeting organizations seeking innovative and flexible research solutions to support the early stages of drug discovery.
Advancing Drug Discovery
Successful drug discovery requires more than individual expertise. It depends on combining innovative biology, robust experimental platforms and multidisciplinary scientific knowledge to solve increasingly complex research challenges.
For more than 25 years, Axxam has collaborated with pharmaceutical companies, biotechnology firms, start-ups, academic institutions and foundations worldwide, providing integrated discovery services that help accelerate the identification and validation of new therapeutic opportunities.
Our multidisciplinary teams support projects from the earliest phases of discovery, helping researchers generate high-quality data that informs critical scientific decisions and reduces development risk.
Our capabilities include:
- Custom assay development for complex biological targets
- Cell-based and cell-free screening platforms
- High-throughput and ultra-high-throughput screening
- Hit identification and hit-to-lead support
- Human iPSC-derived disease models
- High-content imaging and phenotypic screening
- Electrophysiology and functional pharmacology
- Mechanism-of-action studies and translational biology
- Integrated drug discovery solutions tailored to each project
By combining these capabilities within a single organization, Axxam helps clients move efficiently from biological hypothesis to validated discovery candidates.
Meet Axxam at Nordic Life Science Days 2026
Representing Axxam during Nordic Life Science Days 2026 will be Aurélie Dos Santos, Associate, Business Development & Sales for France, Benelux and the Nordics.
AurĂ©lie will be available throughout the event to discuss how Axxam’s scientific expertise can support discovery programs across a wide range of therapeutic areas and research strategies.
Why Meet at Nordic Life Science Days?
Nordic Life Science Days is recognized as one of the premier partnering conferences in Northern Europe, offering a unique opportunity to establish meaningful connections between innovators across the life sciences community.
The event brings together organizations developing novel therapeutics, advanced technologies and next-generation healthcare solutions, creating valuable opportunities to exchange ideas, evaluate new collaborations and discuss future projects.
For companies looking to accelerate research while maintaining scientific quality and flexibility, face-to-face discussions often represent the first step toward building successful long-term partnerships.
If you are attending NLSDays 2026, we would be delighted to learn more about your research challenges and explore how Axxam’s integrated drug discovery expertise can help move your program forward.
We look forward to welcoming you in Stockholm.
Schedule a meeting with Aurélie Dos Santos during Nordic Life Science Days 2026 to discover how Axxam can support your next drug discovery project.